Skip to main content
Cell Reports Methods logoLink to Cell Reports Methods
. 2023 Nov 6;3(11):100626. doi: 10.1016/j.crmeth.2023.100626

Dual stop codon suppression in mammalian cells with genomically integrated genetic code expansion machinery

Birthe Meineke 1,2,, Johannes Heimgärtner 1,2, Rozina Caridha 1,2, Matthias F Block 1, Kyle J Kimler 1, Maria F Pires 1, Michael Landreh 3, Simon J Elsässer 1,2,4,∗∗
PMCID: PMC10694491  PMID: 37935196

Summary

Stop codon suppression using dedicated tRNA/aminoacyl-tRNA synthetase (aaRS) pairs allows for genetically encoded, site-specific incorporation of non-canonical amino acids (ncAAs) as chemical handles for protein labeling and modification. Here, we demonstrate that piggyBac-mediated genomic integration of archaeal pyrrolysine tRNA (tRNAPyl)/pyrrolysyl-tRNA synthetase (PylRS) or bacterial tRNA/aaRS pairs, using a modular plasmid design with multi-copy tRNA arrays, allows for homogeneous and efficient genetically encoded ncAA incorporation in diverse mammalian cell lines. We assess opportunities and limitations of using ncAAs for fluorescent labeling applications in stable cell lines. We explore suppression of ochre and opal stop codons and finally incorporate two distinct ncAAs with mutually orthogonal click chemistries for site-specific, dual-fluorophore labeling of a cell surface receptor on live mammalian cells.

Keywords: Genetic code expansion, amber suppression, stop codon suppression, mammalian cell culture, non-canonical amino acids, unnatural amino acids, bioorthogonal labeling, click chemistry, random genomic integration

Graphical abstract

graphic file with name fx1.jpg

Highlights

  • Stable genetic code expansion with ncAA incorporation in human cancer cell lines

  • Critical parameters and limitations for stop codon suppression in stable cell lines

  • Combination of tRNA/aaRS pairs for dual suppression and two-color click chemistry

  • Dual-color labeling of a genomically encoded surface receptor on live mammalian cells

Motivation

Genetic code expansion via stop codon suppression is a powerful strategy to engineer proteins. Pyrrolysine tRNA (tRNAPyl)/pyrrolysyl-tRNA synthetase (PylRS) pairs from methanogenic archaea and engineered bacterial tRNA/aminoacyl-tRNA synthetase (aaRS) pairs are used for site-specific incorporation of non-canonical amino acids (ncAAs) in response to stop codons in mammalian cells. Routinely, ncAA incorporation is achieved by transient expression of the tRNA/aaRS pair leading to heterogeneous suppression. Genomic integration of tRNA/aaRS expression cassettes for more homogeneous, adjustable, and reproducible levels of protein, containing one or more ncAAs, will greatly benefit synthetic protein production, functional protein engineering, chemical control, and imaging applications in mammalian cells.


Meineke et al. generate stable genomic integrant mammalian cell lines for suppression of each one of the three stop codons, as well as dual stop codon suppression with two distinct non-canonical amino acids. Site-specific non-canonical amino acid insertion enables selective protein labeling using bioorthogonal chemistries, especially for cell surface receptors.

Introduction

The genetic code assigns all possible triplet codons to one of the canonical amino acids (sense codons) or to a translation stop signal (stop codons). Genetic code expansion (GCE), i.e., genetic encoding of non-canonical amino acids (ncAAs), requires reprogramming of a codon. Most commonly, the amber (TAG) stop codon is repurposed, using an engineered tRNA/aminoacyl-tRNA synthetase (aaRS) pair to deliver an ncAA-charged tRNA to the ribosome.1,2 The amber codon is the least abundant and most efficiently suppressed stop codon in mammalian cells. The other two stop codons, TAA (ochre) and TGA (opal), and synthetic quadruplets have also been employed for ncAA incorporation in mammalian cells and enable dual ncAA incorporation via dual suppression.3,4,5,6,7,8,9

In the Methanosarcinaceae family of archaea, specific amber codons in mRNAs coding for enzymes of the methanogenic pathway are suppressed by pyrrolysine tRNA (tRNAPyl; encoded by the PylT gene).10 tRNAPyl and pyrrolysyl-tRNA synthetase (PylRS; encoded by the PylS gene) have characteristics that make them ideal for genetic code expansion in model organisms: the conserved fold of tRNAPyl allows specific interaction with PylRS independent of anticodon identity, and the relatively promiscuous amino acid binding pocket of PylRS readily accommodates structurally diverse ncAAs.11,12 This broad substrate specificity has been further increased by protein engineering: over 100 ncAAs can be incorporated by PylRS variants (reviewed in Wan et al.13). Importantly, the tRNAPyl/PylRS pair is orthogonal to prokaryotic and eukaryotic tRNAs and aaRS.14 These features have made the pairs from Methanosarcina mazei (Mma) and Methanosarcina barkeri (Mba) widely used tools for site-specific integration of a plethora of ncAAs by amber suppression in bacterial, eukaryotic, and mammalian host systems and animals.15

Another approach to expand the genetic code by amber suppression relies on engineering of canonical tRNA/aaRS pairs from one organism in a host of a different clade of life. This has been achieved for both E. coli tyrosyl-tRNA synthetase (EcoTyrRS) and leucyl-tRNA synthetase (EcoLeuRS) by changing the anticodon of the cognate tRNA to CUA and sequential rounds of selection for orthogonality and efficient amber suppression. An engineered EcoTyrRS mutant, AzFRS, has been shown to enable effective incorporation of p-azido-phenylalanine (AzF) with either EcotRNATyrCUA or B. stearothermophilus tRNATyrCUA (BsttRNATyrCUA).16,17,18,19 Further engineering of EcoTyrRS expanded the spectrum of ncAA substrates.20 EcoLeuRS-derived Anap-2C (AnapRS) paired with EcotRNALeuCUA allows introduction of the minimal fluorescent ncAA 3-(6-acetylnaphthalen-2-ylamino)-2-amino-propanoic acid (Anap) in mammalian cells.21,22,23

In mammalian cell culture, components of the amber suppression machinery, i.e., the tRNA/aaRS pair and the reporter or gene of interest with an amber codon, are commonly expressed in transient. Lipofection methods allow for easy delivery of multiple copies of the expression vectors into the cell, but the resulting populations are heterogeneous in expression levels, and endogenous transcripts are outcompeted by the transgene.24 For prolonged and homogeneous protein production, extended expression experiments, selection of homologous expression within a cell population, and other applications, amber suppression cell lines with all components of the genetic code expansion machinery genomically integrated are desirable. We have used piggyBac (PB) transgenesis to achieve genetic code expansion from stable integrants previously.25,26,27 PB transposition utilizes a deconstructed transposon cassette: cotransfection of a PB transposase (PBT) expression plasmid with a second plasmid, containing an integration cassette flanked by inverted repeats recognized by PBT, leads to random genomic integration of the cassette at TTAA sites in the host genome. Integrants are selected by antibiotic resistance markers included in the inserted cassette. While PB transgenesis is known to allow multiple integration events per cell,28 expression of the protein of interest is expected to be much lower and closer to high-expressing endogenous genes than expression after transient transfection. Therefore, stable genetic code expansion is commonly viewed as inefficient. Lower, genomic levels of the gene of interest may increase the competition with off-target suppression at endogenous amber codons, raising the question of how selectivity toward the transgene’s stop codon can be achieved in an endogenous expression context.29 The comprehensive characterization of stable suppression systems for understanding the opportunities and limitations of transgenic cell lines is therefore important. In the present study, we aimed to create a panel of representative cell lines and systematically characterize efficiency and selectivity of amber suppression using PB transgenesis. We demonstrate that stable genetic code expansion greatly varies in efficiency in different model cell lines but can rival transient expression in specific settings and enable efficient single and dual stop codon suppression.

Results

Integration of amber suppression machinery into the genome of human cell lines by PB transgenesis

We previously developed a plasmid system for generation of stable amber suppression cell lines (pAS plasmids) using Mma tRNAPyl/PylRS (tRNAPyl/PylRS hereafter) (Figure 1A)25,26: one plasmid contains the PylS open reading frame (ORF) for PylRS expression and a second encodes a GFP150TAG reporter gene, each controlled by the EF1α promoter. Both plasmids comprise four tandem repeats of 7SK PolIII-controlled PylT genes for tRNAPyl expression. A puromycin or blasticidin resistance marker is expressed from an internal ribosome entry site (IRES) in the PylS or GFP transcripts to allow selection of integrants, respectively. The expression cassette is flanked on both ends by insulator sequences and inverted repeats for PB transposition. This plasmid design allowed for the highest suppression efficiency in transient expression compared to other systems,30 and we have successfully employed pAS plasmids for both transient transfection and stable integration in the past.5,8,25,27,31

Figure 1.

Figure 1

PB transgenesis integrates genetic code expansion machinery into the host cell genome

(A) Schematic representation of pAS (amber suppression) PB transgenesis plasmids. N-terminally FLAG-tagged PylRS is expressed under the control of the EF1α promoter. An internal ribosome entry site (IRES), followed by a puromycin resistance selectable marker (PuroR), is positioned immediately downstream of PylRS. A cassette of four tandem repeats of PylT each controlled by h7SK PolIII promoter for tRNAPyl transcription are positioned upstream of the EF1α promoter. The entire tRNAPyl/PylRS coding cassette is flanked by insulator sequences (Ins) and 3′ and 5′ inverted repeats for genomic integration by PB transposase (pink triangle). The GFP150TAG amber suppression reporter plasmid has the same architecture but contains a blasticidin resistance marker (Bsd).

(B) Immunoblot comparing GFP150CpK reporter expression in different mammalian PB integrant cell lines. The chemical structure of CpK is shown at the top. HEK293T (lanes 1 and 2), HEK293 (lanes 3 and 4), HCT116 (lanes 5 and 6), A375 (lanes 7 and 8), COS-7 (lanes 9 and 10), and U-2 OS (lanes 11 and 12) PB amber suppression integrants were cultured with 0.5 mM CpK (+, even-numbered lanes) or without ncAA (–, odd-numbered lanes) for 24 h. Soluble lysates were SPIEDAC labeled with 1 μM tetSiR and normalized for total protein content. SiR fluorescence was imaged at 630 nm in gel after SDS-PAGE. Immunostaining for GFP expression levels, FLAG-PylRS, and GAPDH is shown.

(C) Quantification of GFP fluorescence in lysates of a low selected (2 μg/mL puromycin, 500 μg/mL blasticidin), stable PylT, PylS, and GFP150TAG integrant HEK293T cell line. Where indicated (yellow shading), the cell line was transiently transfected with different pAS plasmids bearing 4xPylT and/or PylRS variants. Transfections were performed in quadruplicate with 0.2 mM CpK addition for 24 h in triplicate. GFP fluorescence signal is normalized to untransfected cells cultured in the presence of 0.2 mM CpK for 24 h, and background fluorescence (–CpK) values were subtracted. Plasmids transfected by lane: lane 2: no transfection; lane 3: pAS control plasmid; lane 4: pAS (4xPylT); lane 5: pAS_MmaPylRS (PylRS); and lane 6: pAS_4xMmaPylT/RS (4xPylT and PylRS). Error bars indicate standard deviation of the mean of +CpK triplicates. Results from two-sided unpaired t test are shown. The significance was defined in thresholds of p < 0.05 and p < 0.01 as indicated.

(D) Immunoblot for PylRS in lysates shown in (C). Lanes 1 and 2: no transfection without (−) and with (+) CpK, respectively, with the other lanes as in (C). Soluble lysates were separated by SDS-PAGE. Immunostaining for FLAG-PylRS and β-actin is shown.

(E) Flow cytometry comparing amber suppression in HEK293T (top), HEK293 (middle), and HCT116 (bottom) after transient transfection (left) and PB transgenesis (right). Cells were transfected transiently for tRNAPyl/PylRS and GFP150TAG reporter expression. Alternatively, the same plasmids were genomically integrated by PB transgenesis. GFP fluorescence from the sfGFP150TAG reporter was measured after 24 h without ncAA (dashed black line) or in the presence of 0.2 mM CpK (green line).

Common immortalized animal cell lines differ in their characteristics with regard to transgene expression and ease of transfection. We compare PB-mediated integration of our amber suppression system, consisting of PylT, PylS, and the GFP150TAG reporter, across a panel of commonly used cell lines. The two plasmids were cotransfected with the PBT plasmid into the human embryonic kidney cell lines HEK293 and HEK293T, the human colon cancer cell line HCT116, the human melanoma cell line A375, and the osteosarcoma cell line U-2 OS as well as the primate cell line COS-7. The resulting stable polyclonal pools were grown in the presence or absence of N-ε-[(2-methyl-2-cyclopropene-1-yl)-methoxy] carbonyl-L-lysine (CpK). GFP was only expressed in presence of CpK as evident from anti-GFP immunoblotting (Figure 1B, even-numbered lanes). We used strain-promoted inverse electron-demand Diels-Alder cycloaddition (SPIEDAC) between CpK and tetrazine-silicon rhodamine (tetSiR) in lysates to visualize CpK incorporation.32 A single band corresponding to GFP150CpK-tetSiR showed selective ncAA incorporation in all cell lines generated (Figure 1B). Faint additional bands indicated low-level incorporation of ncAAs into various endogenous proteins. The amount of GFP150CpK produced greatly differed between cell lines. HCT116-derived cells produced the strongest GFP signal, followed by HEK293T and HEK293 cells. Curiously, PylRS protein levels were increased or decreased upon ncAA addition in some cell lines, and PylRS expression levels did not correlate with production of full-length GFP. We did not further investigate this phenomenon. While lysates were normalized by total protein content before gel separation, GAPDH levels varied, presumably because of cell-type-dependent expression patterns.

PylT gene copy number is limiting in HEK293T stable amber suppression cell lines

Experiments varying the copy number of tRNA and aaRS in transient transfections or viral transductions have previously helped to establish that low suppressor tRNA levels limit amber suppression efficiency.33,34 To determine which components are limiting amber suppression in our stable integrant system, we transfected a relatively inefficient HEK293T amber suppression cell line with different pAS constructs to increase the gene copy number of PylT, PylS, or both. A control pAS plasmid did not change GFP150CpK or PylRS expression (lanes 1–3, Figures 1C and 1D). Transfection with pAS expressing PylRS led to a strongly increased PylRS protein level but no increased amber suppression efficiency (lane 4, Figures 1C and 1D). Addition of pAS with either 4xPylT or 4xPylT/PylRS enhanced GFP150CpK expression (lanes 5 and 6, Figures 1C and 1D). The GFP fluorescence increased 2.5-fold with transient transfection of pAS 4xPylT and tripled with pAS with 4xPylT/PylRS. Amber suppression did not improve by further increasing the PylT gene dosage with pAS 8xPylT or by expressing reported optimized tRNAPyl variants M15 or A2-1 (Figure S1A).6,35 Like wild-type PylRS, the chimeric Mba/MmaPylRS IPYE mutant had no effect on amber suppression, despite its reported higher catalytic rate36 (Figure S1A). This indicates that tRNAPyl levels can limit amber suppression when they are exclusively expressed from randomly integrated pAS transgenes. The comparably high levels of amber suppression achieved in transient transfection are therefore linked to a high PylT gene copy number leading to high levels of tRNAPyl, while PylRS expression and activity are not rate limiting.

Comparison of transient and stable amber suppression

We further compared amber suppression efficiency of stable polyclonal HEK293, HEK293T, and HCT116 cell lines with their transiently transfected counterparts. After 24 h incubation with CpK, transiently transfected HEK293T cells express GFP150CpK very heterogeneously: flow cytometry shows 60% GFP-positive cells, but the level of GFP fluorescence varies greatly within that population. Stable HEK293T cells produced a less extreme but more homogeneous level of GFP reporter fluorescence between 102 and 103 arbitrary units (Figure 1E). While HEK293 and HCT116 cells showed much reduced transfection efficiency, stable cell lines exhibit efficient suppression across the entire population.

We compared GFP fluorescence (indicative of the total yield of GFP) of the PB integrant cell lines to control cell lines, generated with a non-amber GFP150AAG pAS reporter plasmid, in the same HEK293T, HEK293, and HCT116 parental backgrounds (Figure S1B). The suppression efficiency, calculated as the ratio of mean GFP fluorescence of GFP150CpK and non-amber GFP, ranged from 11% in HEK293 to 47% and 50% in HCT116 and HEK293T cells, respectively. The GFP150CpK expression in stable HCT116 cells was more than 1.5 times higher compared to transiently transfected HEK293T cells, suggesting that transgenic HCT116 cells are an excellently suited host for producing ncAA-containing proteins (Figure S1C).

We further confirmed this finding using a different ncAA and PylRS variant: the chimeric Mma/Mba PylRS variant AbKRS-chIPYE,36,37,38 engineered for incorporation of the photocrosslinking ncAA 3′-azibutyl-N-carbamoyl-lysine (AbK), also produced an efficiently amber suppressing polyclonal population of HCT116 cells (Figures S1D and S1E).

PB transgenesis with E. coli-derived tRNA/aaRS amber suppression pairs in HCT116 cells

We generated pAS constructs for AzF and Anap incorporation analogous to our tRNAPyl/RS two-plasmid system (Figure S2A): AzFRS was combined with BsttRNATyrCUA (tRNATyrCUA/AzFRS), AnapRS was combined with EcotRNALeuCUA (tRNALeuCUA/AnapRS), and both pAS constructs were designed with a geneticin (neomycin) selectable marker. The cognate suppressor tRNA/GFP150TAG reporters were also generated.

We compared amber suppression efficiency of transient transfection and PB transgenesis for AzFRS-mediated amber suppression in HCT116 cells, measuring GFP fluorescence by flow cytometry after 24 h with AzF. Transient transfection of HCT116 cells was again inefficient. Selection with geneticin and blasticidin for PB-mediated integration of tRNATyrCUA/AzFRS and tRNATyrCUA/GFP150TAG produced a heterogeneous pool, but the fraction of GFP-positive cells in the presence of AzF increased from 4.7% in transient transfection to 39.2% (Figure 2A). Fluorescence-activated cell sorting (FACS) of the polyclonal pool for single, strongly GFP-expressing cells isolated clonal populations with very high amber suppression efficiency (Figure S2B). Evidently, the tRNATyrCUA/AzFRS pair can support extremely efficient amber suppression from integrated transgenes.

Figure 2.

Figure 2

PB integration for tRNATyrCUA/AzFRS and tRNALeuCUA/AnapRS mediated amber suppression in HCT116 cells

(A) Flow cytometry of amber suppression cell line generated with E. coli TyrRS-derived AzFRS. The chemical structure of AzF is shown. HCT116 cells were transiently transfected for expression of tRNATyrCUA/AzFRS and the corresponding tRNATyrCUA/GFP150TAG reporter (transient, top). The same plasmids were integrated by PB transgenesis (integration, bottom). GFP fluorescence from the sfGFP150TAG reporter was measured after 24 h without ncAA (dashed black line) or in the presence of 0.5 mM AzF (green line).

(B) Flow cytometry of amber suppression cell line generated with E. coli LeuRS-derived AnapRS. The chemical structure of Anap is shown. HCT116 cells were transiently transfected for tRNALeuCUA/AnapRS and cognate tRNALeuCUA/GFP150TAG reporter (transient, top). The same plasmids were integrated by PB transgenesis (integration, bottom). Cells were cultured with 0.05 mM Anap (cyan) or without ncAA (black), followed by a 2 h chase with ncAA-free medium prior to measurement of GFP and Anap fluorescence.

(C) Immunoblotting of lysates prepared from transiently transfected and PB integrant HCT116 cells cultured in the presence of ncAA as in (A) and (B). Samples were separated by SDS-PAGE and immunostained for GFP150ncAA, FLAG-AzFRS, and an actin loading control.

We similarly compared the polyclonal pool of stable tRNALeuCUA/AnapRS and tRNALeuCUA/GFP150CpK integrants with transiently transfected cells. Here, we assessed both GFP and Anap fluorescence by flow cytometry (Figure 2B). The polyclonal pool of stable integrants showed strong GFP and Anap fluorescence when incubated with the ncAA for 24 h, indicating expression of GFP150Anap (Figures 2B and S2C). A fluorogenic ncAA like Anap ideally allows direct detection of the protein of interest; however, unincorporated and misincorporated ncAAs can contribute substantially to signal intensity. To assess the contribution of misincorporated Anap in endogenous proteins, we generated an HCT116 cell line with integrated tRNALeuCUA/AnapRS without an amber suppression reporter. When cultured in the presence of Anap for 24 h, this AnapRS-only integrant cell line produced no GFP fluorescence, but Anap fluorescence was clearly detectable by flow cytometry, despite extensive ncAA washout before measurement (Figures S2C–S2E). Evidently, Anap was retained in the cell in aminoacyl-tRNA complexes or was incorporated at off-target amber codons even in the absence of mRNA with a premature amber codon.

Total GFP yield, as determined by western blot, was higher in stable AzFRS and AnapRS amber suppression HCT116 cell lines compared to transient transfection (Figure 2C). We confirmed AzFRS expression via a C-terminal FLAG tag after stable integration, while AnapRS, expressed in its originally described tagless form,21,22 could not be probed.

Generation of efficient amber-, ochre-, and opal-suppressing clonal populations by PB transgenesis of HCT116 cells

The amber codon is most widely used in genetic code expansion in mammalian cells because it is the least abundant stop codon (23% in the human genome), and amber suppression efficiency is superior to suppression of either of the other two stop codons, ochre (TAA) or opal (TGA), in transient transfections.4,5,8 We sought to explore if genomic integration would allow for selection and isolation of efficient ochre- and opal-suppressor populations, a prerequisite for incorporating more than one ncAA site specifically in response to two different stop codons in a stable cell line. We generated 4x7SK PylT cassettes for expression of ochre- and opal-suppressor tRNAs, tRNAPylUUAand tRNAPylUCA, and combined them with PylRS and their cognate GFP reporter, GFP150TAA or GFP150TGA, respectively. In transient transfection, neither ochre nor opal suppression was efficient in HCT116 cells (Figure 3A, left column). Selection for stable integration yielded polyclonal pools of HCT116 cell lines that express GFP150CpK. GFP yield of the ochre- and opal-suppression polyclonal populations was, however, more than an order of magnitude lower (mean fluorescence: 81 and 109 arbitrary units, respectively) than amber suppression (mean: 1,687 arbitrary units) (Figures 3A, center column, and S3A). We isolated clones from the polyclonal population by FACS, selecting for single cells with a strong GFP signal after 24 h incubation with CpK. Six amber-, nine ochre-, and one opal-suppressing clones were recovered and compared for GFP expression by flow cytometry (Figures S3A and S3B). For each clone, the addition of CpK resulted in homogeneous GFP fluorescence at a higher intensity than observed for the polyclonal pool. The most efficiently suppressing clones for each stop codon are shown in Figure 3A (right column). Despite the clonal selection, maximal ochre and opal suppression remained roughly one order of magnitude lower than amber suppression (Figure S3B). This confirmed the observation from transient transfection experiments that ochre and opal codon suppression is less efficient.3,4,5,6,7,8,9

Figure 3.

Figure 3

Generation of efficient ochre- and opal-suppressor clonal HCT116 populations by PB transgenesis

(A) Flow cytometry comparing amber (TAG, top), ochre (TAA, middle), and opal (TGA, bottom) suppression in HCT116 cells after transient transfection (left) and PB transgenesis (middle and right). GFP fluorescence was measured without ncAA (dashed black line) or 24 h after addition of 0.2 mM CpK (green line). Left: transient transfection with pAS plasmids for tRNAPyl, PylRS, and the GFP150stop reporter; suppressor tRNAs have the indicated CUA, UUA, or UCA anticodons to match the UAG, UAA, and UGA stop codons in the respective GFP reporter mRNA (gray). Center: using the same pAS plasmids, expression cassettes producing PylRS, tRNAPylCUA, tRNAPylUUA, or tRNAPylUCA (black) and the corresponding GFP150stop reporter were genomically integrated by PB transgenesis. Right: clonal populations, isolated from the polyclonal pools (middle) by FACS, after 24 h incubation with 0.2 mM CpK. Best clones are shown for amber, ochre, and opal suppression, respectively. The other recovered clones are compared in Figure S3. Data for amber suppression after transient transfection and stable integration in HCT116 cells are reproduced from Figure 1E.

(B) Immunoblot of lysates from clonal stop codon suppressor HCT116-derived cell lines shown in (A). The asterisk (∗) indicates a stop codon. Clonal populations were cultured with 0.5 mM CpK for 72 h. GFP150CpK was SPIEDAC labeled with 1 μM tetSiR in lysate followed by SDS-PAGE and immunostaining for GFP expression and FLAG-aaRS expression.

Efficient suppression of the target stop codon is typically considered the most important variable for optimization, but the selectivity for ncAA-labeling applications also crucially depends on low misincorporation at endogenous stop codons.29 In order to compare the on- versus off-target incorporation of ncAAs, we compared the best clones for each stop codon after extended CpK incorporation. Cell lysates were labeled by SPIEDAC with tetSiR during lysis (Figure 3B). The most prominent band corresponds to GFP150CpK-tetSiR in each of the three stop codon suppressing cell lines. The ochre suppression clonal cell lysate also featured a distinct band, suggesting a particularly strongly labeled endogenous protein. It is interesting to note that endogenous opal codons do not appear to be more efficiently suppressed by tRNAPyl than the other two stop codons, despite the opal codon being known to show the highest leakiness, i.e., readthrough with endogenous tRNAs.33,39,40 In summary, productive ochre and opal suppression is possible to achieve in stable settings. Yet, as expected, amber suppression of the reporter GFP is markedly more efficient while exhibiting similarly low levels of incorporation into endogenous proteins.

Dual suppression clonal cell line for amber and ochre cosuppression

In recent years, several approaches have successfully implemented dual suppression of two different stop codons in transiently transfected mammalian cells, allowing for site-specific incorporation of two distinct ncAAs.3,4,5,6,7,8 Encouraged by selection of ochre and opal suppressor cell lines expressing high levels of GFP150CpK, we decided to investigate if dual suppression could be implemented in a stable setting. The compatibility of tRNATyrCUA/AzFRS and tRNALeuCUA/AnapRS pairs engineered from E. coli in combinations with archaeal tRNAPyl/PylRS has been explored in detail using transient transfection.4 Choosing the two most efficiently suppressed stop codons (Figure 3A), we explored the combination of the ochre suppressor tRNAPylUUA/PylRS pair with a compatible orthogonal amber suppressor tRNA/aaRS pair for dual integration. We integrated tRNAPylUUA/PylRS, tRNATyrCUA/AzFRS, and a GFP102TAG150TAA dual suppression reporter into HCT116 cells (Figure 4A). After coselection with puromycin, geneticin, and blasticidin, a few cells showed increased GFP fluorescence in the polyclonal pool after 48 h with CpK and AzF. We isolated single cells with high GFP fluorescence by FACS and recovered clonal populations with a varied range of dual suppression efficiency (Figure S4A). The most efficient clone showed robust CpK- and AzF-dependent expression of GFP102AzF150CpK (Figures 4B, 4C, S4B, and S4C). No cross-incorporation of ncAA was observed; there are no GFP-positive cells after incubation with only one of the ncAAs (Figures 4B and 4C). We purified GFP expressed in the presence of AzF and CpK from the clonal cell line (yield 80 ng/mL culture) and confirmed incorporation of both ncAAs by intact mass spectrometry (Figure 4D). In addition to CpK, GFP102AzF150CpK contains AzF, which can also be used for bioorthogonal labeling. The azido group reacts with alkynes in Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) or with strained alkynes in copper-independent strain-promoted AAC (SPAAC). We visualized purified GFP102AzF150CpK by SPIEDAC and SPAAC with tetSiR and dibenzylcyclooctyne-PEG4-5/6-tetramethyl-rhodamine (DBCO-TAMRA), respectively (Figure 4E). In summary, stable cell lines are useful for production of dual suppressed proteins.

Figure 4.

Figure 4

Dual suppression clonal cell line for GFP102AzF150CpK expression in HCT116 cells

(A) Scheme illustrating amber- and ochre-cosuppression in HCT116 cells with tRNAPylUUA/PylRS ochre suppressor pair, tRNATyrCUA/AzFRS amber-suppressor pair, and a GFP102TAG150TAA reporter integrated by PB transgenesis. Addition of AzF and CpK leads to GFP102AzF150CpK production.

(B) Flow cytometry of the HCT116 tRNAPylUUA/PylRS, tRNATyrCUA/AzFRS, and GFP102TAG150TAA clone F6 grown without ncAA (–ncAA, black) or with 0.2 mM CpK (+CpK, orange), with 0.5 mM AzF (+AzF, violet), or both ncAAs (++, green) for 48 h.

(C) Immunoblot for lysates prepared from the GFP102TAG150TAA integrant clone F6 grown without ncAA, with 0.2 mM CpK, with 0.5 mM AzF, or both ncAAs for 48 h. Lysates were separated by SDS-PAGE followed by immunostaining for GFP expression and FLAG-aaRS expression.

(D) Intact mass determination for purified GFP102AzF150CpK expressed in the dual-suppressor clonal cells. Calculated theoretical mass and determined mass are indicated.

(E) GFP102AzF150CpK, purified from the PB dua suppressor HCT116 clone, was labeled by SPAAC and SPIEDAC with 1 μM DBCO-TAMRA and 1 μM tetSiR, respectively. In-gel fluorescence was imaged at 520 nm (for TAMRA) and 630 nm (for SiR) after separation by SDS-PAGE; fluorescence merge and Coomassie-stained gel are shown.

Amber suppression cell lines for cell surface receptor expression

We have so far described PB cell line generation with an easily detectable, well expressed, and stable GFP reporter. To demonstrate the robustness of our approach, we chose a range of other proteins involved in different cellular processes. We generated stable HCT116 amber suppression cells lines for expression of a number of intracellular proteins of interest, either with an internal amber codon or STELLA tag (N-terminal TAG) and C-terminal hemagglutinin (HA) tag31: the cytoskeletal protein tubulin, heterochromatin-associated DAXX, the histone variant CENP-A, and the microproteins PIGBOS and SARS2-CoV-M (Figure S5A). We used the PylRS “AF” variant in these cell lines to incorporate axial trans-cyclooct-2-ene-L-lysine (TCO∗K; Figure 5A).41,42 Polyclonal integrant populations were selected, and all proteins were detectable by immunoblotting for their HA tag, with expected variation in expression levels. SPIEDAC labeling with tetSiR or tetrazine-AF488 (tet488) in cell lysates shows specific bands for the TCO∗K-labeled proteins according to their respective size, although endogenous proteins appear to be labeled with similar or even higher intensity (Figures S5B and S5C). Fluorescence microscopy of fixed and permeabilized cells labeled with methyl-tetrazine-BDP-FL (metetBDPFL) and counterstained for HA further showed that bioorthogonal labeling created a strong ambient background signal across cytosol and nucleus, while a specific signal from the amber suppressed protein was only marginally brighter. This is most evident for the Golgi-restricted CoV-M protein (Figure S5D).31 Therefore, the strong expression and selective suppression of our GFP reporter must be considered an outlier compared to many biologically relevant proteins that are desirable to label using amber suppression. Evidently, the known large plasmid copy number, 10 to 100,000 copies per cell,43 after transient transfection provides a much larger window for selective suppression of the target amber codon than expression from genomic PB integrants. Nevertheless, we considered that mislabeling of endogenous C-terminal amber stop codons may generate predominantly intracellular backgrounds and that using a cell-impermeable dye may allow selective labeling of target proteins on the cell surface.

Figure 5.

Figure 5

Amber suppression cell lines for bioorthogonal labeling of cell surface receptors

(A and B) Fluorescence microscopy imaging of HCT116 PB integrant cell lines for cell surface receptor expression by amber suppression with (A) tRNAPyl/PylRS AF and CRFR195TAG or (B) tRNAPyl/PylRS AF and SynNotch442TAG. Integrant populations recovered after selection were cultured with 0.1 mM TCO∗K for 48 h, chased in ncAA-free medium for 2 h prior to SPIEDAC labeling with 1 μM tetCy3. Cells were fixed in paraformaldehyde (PFA), and nuclei were counterstained with Hoechst 33342 prior to imaging on a Nikon Ti2. White scale bars indicate 25 μm.

(C) Immunoblot for the same cell lines as in (A) and (B) expressing CRFR195TCO∗K or SynNotch442TCO∗K. Cells were cultured with 0.1 mM TCO∗K for 48 h. The cell surface receptors were either labeled by SPIEDAC with 2 μM membrane-impermeable tet488 before lysis or with 1 μM tetSiR in cell lysate. Cleared lysate aliquots were separated by SDS-PAGE, and tet488 surface fluorescence and tetSiR lysate labeling visualized at 460 nm (for 488, cyan) and 630 nm (for SiR, magenta), respectively. Immunostaining for the C-terminal HA tags confirms specific SPIEDAC surface labeling of CRFR195TCO∗K and SynNotchN442TCO∗K. Immunostaining for FLAG-PylRS AF is shown. The SynNotch illustration was simplified by omitting the N-terminal LaG17 fusion.

To test this hypothesis, we used two cell surface receptors for generation of stable amber suppression HCT116 cell lines: first, the class B G protein-coupled receptor (GPCR) corticotropin-releasing factor type 1 receptor (CRFR1). CRFR1 A95TAG has previously been used in amber suppression studies for ncAA-mediated bioorthogonal labeling on the surface of live cells.6,8,44,45

Second, we used a minimal synthetic Notch (SynNotch) receptor: an amber codon at N442 in our construct (N1713 in human Notch1) places the ncAA on the cell surface close to the membrane spanning helix of the C-terminal fragment generated by proteolysis during maturation of the receptor.8,46

Polyclonal stable cell lines for each receptor were cultured with TCO∗K for 48 h, and live cells were SPIEDAC labeled with tetrazine-Cy3 (tetCy3) and subsequently fixed for microscopy. CRFR195TCO∗K- and SynNotch442TCOK-expressing cells showed a strong, TCO∗K-dependent tetCy3 signal on the surface of cells (Figures 5A and 5B). Expression levels were much more homogeneous across the population compared to transient transfection.8 The same CRFR195TAG and SynNotch442TAG cell lines were labeled live with tet488, and lysates were labeled with tetSiR for comparison (Figure 5C). While the tet488 signal was highly specific for the cell surface receptor and overlapped with the HA-immunostaining signal, tetSiR in lysates preferentially labeled endogenous proteins. In summary, stable amber suppression cell lines provide limited opportunity for selective bioorthogonal labeling of intracellular proteins, but do enable efficient suppression and labeling of extracellular receptors, offering an ideal platform for biophysical studies of membrane receptors in their native environment.

Dual site-specific ncAA incorporation and dual-color labeling by combined amber and ochre suppression in transgenic HCT116 cells

Building on our promising results for combining amber and ochre suppression with tRNAPylUUA/RS and tRNATyrCUA/AzFRS for the GFP reporter, we attempted generation of stable dual suppression cell lines in HCT116 cells for SynNotch. The SynNotch204TAA442TAG amber and ochre double mutant can incorporate two distinct ncAAs for dual bioorthogonal derivatization when transiently cotransfected with appropriate, orthogonal tRNA/aaRS pairs. The incorporation sites are designed to place the two ncAAs in close spatial proximity to each other but on separate parts of the mature, proteolytically processed SynNotch receptor.8

Initial attempts to generate PB transgenic cell lines for SynNotch204TAA442TAG-HA failed, even when we exchanged the ochre suppressor tRNAPylUUA for the M15 mutant,6 which we had found to enhance ochre suppression efficiency before.8 We recovered PylRS- and AzFRS-expressing populations after selection, yet were unable to detect ncAAs or HA tag (data not shown). To facilitate selection of integrants with SynNotch receptor expression by FACS, we exchanged the C-terminal HA tag for a GFP tag. We transfected HCT116 cells with M15UUA/PylRS, tRNATyrCUA/AzFRS, M15UUA/SynNotch204TAA442TAG-GFP, and PBT. After selection with geneticin, puromycin, and blasticidin, GFP fluorescence could be detected in a small number of cells after culturing in the presence of AzF and CpK for 3 days. From this population, we isolated single cells by FACS for the highest GFP fluorescence (Figure S6A). The best clone recovered showed increased GFP fluorescence with both ncAAs over a 12 to 72 h time course (Figure S6B). Flow cytometry and imaging of this clone confirmed that GFP fluorescence was not the result of cross-incorporation, readthrough with endogenous amino acids, or a secondary translation start, as it localized to the cell membrane and depended on the addition of both CpK and AzF (Figure 6A and S6C).

Figure 6.

Figure 6

Dual suppression HCT116 clonal cell line for SynNotch204CpK442AzF expression and live-cell dual-bioorthogonal labeling

(A) The HCT116 dual suppressor clone, with M15UUA/PylRS ochre suppressor pair, tRNATyrCUA/AzFRS amber suppressor pair, and SynNotch204TAA442TAG-GFP integrated via PB transgenesis, was cultured 72 h without ncAA (–ncAA, black) or with 0.2 mM CpK (+CpK, orange), 0.5 mM AzF (+AzF, purple), or both ncAAs (++, green) and analyzed by flow cytometry for GFP fluorescence. The positions of both ncAAs in the mature receptor are illustrated in the schematic. SynNotch illustrations are simplified by omitting the N-terminal LaG17 fusion.

(B) SynNotch204CpK442AzF-GFP purified from the dual suppression HCT116 integrant clone. Bioorthogonal labeling by SPAAC and SPIEDAC with 2 μM DBCO-647 and 2 μM tetCy3, respectively. In-gel fluorescence of the bead-captured protein after separation by SDS-PAGE, 520 nm (for Cy3) and 630 nm (for AF647) imaging, and merged signals are shown, as well as immunoblotting against the C-terminal GFP. The different domains and processing states of SynNotch are indicated as follows: white arrow, 81 kDa preprocessed SynNotch204CpK442AzF; yellow arrow, 43 kDa N-terminal domain with 204CpK labeled by tetCy3; magenta arrow, 38 kDa C-terminal TMD-GFP fusion with 442AzF labeled by DBCO647; and yellow asterisk, additional SynNotch N-terminal fragment after proteolytic cleavage of LaG17.8

(C) Fluorescence microscopy for dual bioorthogonal labeling of SynNotch204CpK442AzF-GFP expressed in the clonal dualsuppressor clone. Cells were cultured with 0.2 mM CpK and 0.5 mM AzF for 72 h and labeled with 2 μM tetCy3 by SPIEDAC and 2 μM alk647 by CuAAC, respectively. Prior to imaging on a Nikon Ti2, nuclei were counterstained with Hoechst 33342. White scale bar indicates 25 μm. See also Figure S6E.

(D) SDS-PAGE gel separation of lysates from SynNotch204CpK442AzF-GFP expressing dual suppressor HCT116 clone. SPIEDAC and CuAAC labeling with 2 μM tet488 and 2 μM alk647 on live cells cultured with 0.2 mM CpK and 0.5 mM AzF for 72 h. In-gel fluorescence after separation, excitation 460 (for AF488) and 630 nm (for AF647), and immunoblotting against the C-terminal GFP are shown. Arrows indicate the different processing states of SynNotch: cyan arrow indicates the 43 kDa N-terminal domain containing 204CpK-tet488 after SPIEDAC; magenta arrow indicates 38 kDa C-terminal TMD-GFP fusion comprising 442AzF-alk647; and asterisk indicates an additional SynNotch N-terminal fragment without LaG17.8.

We validated the functionality of the two ncAAs for dual bioorthogonal labeling with tetCy3 and DBCO-AF647 (DBCO-647) by SPIEDAC and SPAAC, respectively, on SynNotch204CpK442AzF-GFP purified from the clone (Figure 6B). In SDS-PAGE, the two proteolytic fragments of SynNotch are separated. The Cy3 and 647 fluorescence signals are isolated, which demonstrates that each receptor domain is selectively labeled and confirms site-specific incorporation of the two ncAAs. As expected, the DBCO647 signal from the AzF-labeled C-terminal transmembrane domain overlapped with the anti-GFP immunostaining signal. We observe two diffuse bands for the glycosylated N-terminal domain, due to partial proteolytic cleavage after the nanobody domain.8 A small portion of unprocessed SynNotch204CpK442AzF-GFP was also captured, visible as a faint high-molecular-weight band in both fluorescence channels and immunoblotting. We validated the band assignment by dual suppression of transiently transfected SynNotch204TAA442TAG-GFP and SPIEDAC labeling on live cells, which resulted in the same pattern (Figure S6D).

Live-cell dual-color bioorthogonal labeling of a receptor in stable cell lines

Next, we investigated if the clonal stable dual suppression cell line produced sufficient SynNotch204CpK442AzF-GFP for live-cell labeling. Cells were grown in the presence of both ncAAs for 72 h, labeled with tetCy3 and alkyne-AF647 (alk647), and imaged for fluorescence of both dyes (Figure 6C). We detected overlapping, ncAA-dependent cell surface signals for all three fluorophores associated with SynNotch204CpK442AzF-GFP. The Cy3, 647, and GFP fluorescence signals were dependent on the addition of both ncAAs. When CuAAC was performed on live cells, both GFP and Cy3 signals were decreased, highlighting the potential of copper to damage cellular proteins even at a low concentration (Figure S6E). Using a copper-free SPAAC reaction with DBCO-467 as an alternative for labeling AzF, however, was not successful, as it led to strong unspecific labeling of endogenous proteins (Figure S6F).47

SynNotch204CpK442AzF-GFP-expressing cells labeled by SPIEDAC and CuAAC under live conditions yielded the same band pattern observed for affinity-purified SynNotch204CpK442AzF-GFP when separated by SDS-PAGE (Figure 6D). Two ncAA-dependent bands with tet488 fluorescence are visible for the N-terminal SynNotch domain, due to partial proteolysis as previously observed. An additional higher-molecular-weight band represented an artifact of tet488 surface labeling since it was present in all dye-treated samples, even in the absence of ncAAs (Figure 6D). After CuAAC labeling a single fluorescent band is visible, corresponding to C-terminal transmembrane domain (TMD)-GFP, comprising N442AzF specifically labeled by alk647 (Figure 6D). SPAAC labeling of SynNotch204CpK442AzF-GFP with DBCO-647 led to a diffuse signal across the entire lane, owing to the unspecific DBCO reactivity we also observed during microscopy (Figure S6G).47 Taken together, our results demonstrate that dual suppression and bioorthogonal derivatization of two distinct ncAAs with two mutually orthogonal reactions is possible in a stable cell line with integrated suppression machinery. The resulting fluorescence signal strength was limited by the low efficiency of dual stop codon suppression and by the limited choice of mutually orthogonal reactions.

Discussion

Systematic evaluation of suppression systems and mammalian host cell lines enabled us to generate stable cell lines with expanded genetic codes for suppression of all three stop codons using PB transgenesis. We established a universal two-plasmid design for generating mammalian cell lines with the choice of three distinct orthogonal tRNA/synthetase pairs. This versatility should enable incorporation of virtually any genetically encoded ncAA described to date in stable cell lines.

Our approach benefits from the efficiency of PB transgenesis. Optimal clones can be isolated by selection without a priori knowledge of the ideal copy-number configuration. As an alternative to genomic integration, an episomal self-replicating plasmid has been used to long-term express the amber suppression machinery in human hematopoietic stem cells.48 This approach, however, will likely require continuous selection to maintain stable transgene copy number and efficient amber suppression. Stable integration and clonal selection, including by PB transposition, has been also used to generate amber suppression CHO cell lines efficiently expressing ncAA-modified antibodies for drug conjugation.49,50

Building on the toolbox created in this study, we proceeded to demonstrate site-specific incorporation and chemical labeling of two distinct ncAAs in a stable mammalian cell line. Our study highlights opportunities and limitations of dual suppression systems, requiring two selective, efficient, and mutual orthogonal incorporation machineries. The relatively lower efficiency of ochre and opal stop codon suppression limits the overall yield of dual suppressed protein.4,5,8,9 We chose AzF for encoding the CuAAC handle because of its efficient incorporation (Figures 2A and S2B), but this likely limited the fluorescent labeling efficiency on live cells. We have previously shown that a genetically encoded picolyl-azide provided superior CuAAC reactivity with alkyne dyes,45 but orthogonal machineries to introduce picolyl-azide and TCO∗K or CpK do not exist to date.

Limitations of the study

In the present study, we did not systematically assess DNA copy number and resulting relative expression levels of PylRS, tRNAPyl, and the target protein in a larger number of clones. Consequently, a universal recipe for the optimal dosage of tRNA, aaRS, and the gene of interest cannot be derived from our data, and the best condition may be highly context specific with respect to cell line, target protein, and ncAA used. Nevertheless, we find that maximizing tRNA and gene-of-interest expression are determinants of ncAA incorporation efficiency and selectivity. In addition, position and context of the stop codon have been shown to greatly influence suppression efficiency and hence are important parameters to optimize.29

It is an important goal of the field to achieve selective labeling of amber codons in target proteins expressed at the endogenous level or even endogenously edited genes. Our experiments with the GFP reporter demonstrate that, under most optimal conditions, endogenously expressed proteins can be ncAA labeled with high efficiency and good selectivity. However, our data also underscore that such an ideal scenario is unlikely to apply to the average cellular protein. Our methodology provides most attractive applications for labeling proteins on the plasma membrane. Site-specifically incorporated ncAAs on the cell surface face little competition from misincorporated ncAAs at endogenous stop codons due to the fact that C-termini of plasma membrane proteins are mostly intracellular or post-translationally processed. Our stable genetic code expansion technology, together with fluorescent bioorthogonal labeling on the cell surface, provides a valuable toolbox to investigate the localization, movement, and clustering of membrane receptors on the cell surface. Dual color labeling will enable new applications for studying conformational dynamics and multimeric assemblies of cell surface proteins.

STAR★Methods

Key resources table

REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies

Mouse monoclonal anti-GFP Santa Cruz Cat#sc-9996; RRID:AB_627695
Rat monoclonal anti-HA HRP-coupled Roche Cat#12013819001; RRID:AB_390917
Mouse monoclonal anti-FLAG HRP-coupled Sigma Cat#A8592; RRID:AB_439702
Rabbit monoclonal anti-β-actin Cell Signaling Cat#4970; RRID:AB_2223172
Chicken polyclonal GAPDH Millipore Cat#AB2302; RRID:AB_10615768
Goat anti-chicken IgY (H + L) HRP Invitrogen Cat#A16054; RRID:AB_2534727
Goat anti-mouse HRP-coupled BioRad Cat#1721011; RRID:AB_11125936
Goat anti-rabbit HRP-coupled BioRad Cat#1721019; RRID:AB_11125143

Chemicals, peptides, and recombinant proteins

CpK: N-ε-[(2-methyl-2-cyclopropene-1-yl)-methoxy] carbonyl-L-lysine SiChem Cat#SC-8017; CAS:1610703-09-7
ProK: N-propargyl-L-lysine Iris Biotech Cat#HAA2090; CAS:1428330-91-9
TCO∗K: axial trans-cyclooct-2-ene-L-lysine SiChem Cat#SC-8008; CAS:1801936-26-4
Anap: (2S)-3-[(6-Acetylnaphthalen-2-yl)amino]-2-aminopropanoic Acid Cayman Cat#15436; CAS 1313516-26-5
AzF: 4-Azido-L-phenylalanine Santa Cruz Cat#sc-289923; CAS: 33173-53-4
AbK: N6-[[2-(3-Methyl-3H-diazirin-3-yl)ethoxy]carbonyl]-L-lysine SiChem Cat#SC-8034; CAS: 1253643-88-7
tetrazine-Siliconrhodamine (tet-SiR) Spirochrom Cat#SC008
tetrazine-AF488 (tet-488) Click Chemistry Tools Cat#1361
Dibenzylcyclooctyne-PEG4-5/6-Tetramethylrhodamine (DBCO-TAMRA) Jena Bioscience Cat#CLK-A131
Cy3-tetrazine (Cy3-tet) Click Chemistry Tools Cat#1204
alkyne-AF647 (alk-647) Jena Bioscience Cat#CLK-1301A
Dibenzylcyclooctyne-AF647 (DBCO-647) Jena Bioscience Cat#CLK-1302

Critical commercial assays

Pierce BCA assay kit Fisher Scientific Cat#23227
GFP-Trap_MA magnetic beads ChromoTek Cat#gtma

Deposited data

Additional Data and Resources Mendeley data https://doi.org/10.17632/tgc7mbv5xp

Experimental models: Cell lines

Human: HEK293T cells N/A
Human: HEK293 cells N/A
Human: HCT116 cells N/A
Human: A375 N/A
Human: U-2 OS N/A
Simian: COS7 N/A
HCT116 cell clone D9 MmaPylRS wt+GFP150TAG This paper HCT_MmaRS/GFP
HCT116 cell clone E11 MmaPylRS wt+GFP150TAA This paper HCT_MmaRS/GFP ochre
HCT116 cell clone D10 MmaPylRS wt+GFP150TGA This paper HCT_MmaRS/GFP opal
HCT116 cell clone F6 MmaPylRS wt + AzFRS + GFP102TAG150TAA This paper HCT_MmaRS+AzFRS/GFP
HCT116 cell lone D8 MmaPylRS wt + AzFRS + SynNotch 204TAA 442TAG-GFP This paper HCT_MmaRS+AzFRS/SynNotch

Recombinant DNA

Piggy Bac Transposase expression plasmid Sytem Bioscience Cat#PB200PA
pAS_MmaPylT/RS Meineke et al.3 Addgene#140009
pAS_MmaPylT/GFP150TAG Meineke et al.3 Addgene#140015
pAS_MmaPylT/GFP150TAG Meineke et al.6 Addgene#154766
pAS_sfGFP 102TAG 133TGA 150TAA This paper N/A
pAS_MmaPylRS Meineke et al.3 Addgene#154762
pAS (with MmaPylT) Meineke et al.3 Addgene#14008
pAS_MmaPylT/AbKRS This paper Addgene#140020
pAS_BstTyrT(CUA)/EcoTyrRS This paper Addgene#140018
pAS_BstTyrT(CUA)/sfGFP 105TAG This paper Addgene#174891
pAS_MmaPylT/RS AF Meineke et al.3 Addgene#140023
pAS_BstTyrT(CUA)/sfGFP 102TAG 150TAA This paper Addgene#174895
pAS_EcoLeuT(CUA)/AnapRS This paper Addgene#140019
pAS_EcoLeuT/GFP150TAG This paper Addgene#174892
pAS_MmaPylT(UUA)/RS This paper Addgene#174896
pAS_MmaPylT(UUA)/GFP 150TAA This paper Addgene#174897
pAS_MmaPylT(UCA)/RS This paper Addgene#174899
pAS_MmaPylT(UCA)/GFP 150TGA This paper Addgene#174898
pAS_M15(UUA)/MmaRS Meineke et al.6 Addgene#154774
pAS_MmaPylT/CRFR1 95TAG Meineke et al.41 Addgene#174900
pAS_MmaPylT/LaG17-SynNotch 277TAG This paper N/A
pAS_M15(UUA)/LaG17-SynNotch 39TAA 277TAG This paper N/A

Software and algorithms

Fiji Schindelin et al., 2012 Schindelin et al.51 https://fiji.sc; RRID:SCR_002285
FlowJo™ BD Life Sciences v10.6.2 Software

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Simon J. Elsässer (simon.elsasser@scilifelab.se).

Materials availability

A list of PiggyBac integrant cell lines has been deposited to Mendeley data. The DOI is listed in the key resources table. Clonal populations isolated in this study are listed in the key resources table and available on request. Most plasmids used in this study have been deposited to Addgene, all others are available on request.

Data and code availability

  • Raw images have been deposited to Mendeley data, see key resources table for the DOI. All other primary data will be shared by the lead contact upon request.

  • This paper does not report original code.

  • Any other information required to reanalyze the data in this paper will be shared by the lead contact upon request.

Experimental model and subject details

Human cell culture

HEK293 cells (human, sex unknown, epithelial-like embryonic kidney), HEK293T cells (human, sex unknown, epithelial-like embryonic kidney), HCT116 cells (human, male, colon cancer), A375 cells (human, female, malignant melanoma), U-2 OS cells (human, female, osteosarcoma) and COS-7 cells (Cercopithecus aethiops, sex unknown, fibroblast kidney) were maintained in Dulbecco’s modified Eagle’s medium (DMEM, GlutaMAX, Thermo) supplemented with 10% (v/v) FBS at 37°C and 5% CO2 atmosphere.

Method details

DNA constructs

The M. mazei tRNAPyl/PylRS expression and super folder GFP150TAG (referred to as GFP150TAG and GFP throughout) reporter constructs with four tandem h7SK driven PylT repeats, coding for U25C tRNAPyl, have been described previously.5 Analogous constructs for amber suppression by AnapRS and AzFRS with the respective cognate tRNALeuCUA or tRNATyrCUA were generated for this study. The plasmids share a common architecture and are here collectively referred to as “pAS” (AmberSuppression) plasmids: The aaRS, reporter or gene of interest coding sequences are controlled by EF1α promoter and followed by a internal ribosome entry site (IRES) that allows expression of a downstream selection marker. A cassette with four tandem repeats of the tRNA gene, controlled by the human 7SK PolIII promoter, are placed upstream of the EF1αpromoter in anti-sense orientation. A schematic of this architecture is shown in Figure 1A. All DNA constructs were verified by Sanger sequencing. Refer to the key resources table for plasmids used and generated in this study and their Addgene accession number.

Cell culture and transfection

HEK293, HEK293T, HCT116, A375, COS-7 and U-2 OS cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, GlutaMAX, Thermo) supplemented with 10% (v/v) FBS (Sigma) at 37°C and 5% CO2 atmosphere. For transfection (1.5–2.0) x 105 cells/ml were seeded 24 h before transient transfection with 1 μg plasmid DNA/ml using TransIT-LT1 (Mirus) according to the manufacturer’s instructions. In transient transfection experiments, ncAAs were added at the time of transfection and cells were harvested after 24, 48 or 72 h, as indicated.

Generation of PB-mediated stable integration cell lines

Cell lines with PiggyBac (PB) integrated transgenes were generated as described25,26: Parental cells were seeded one day prior to transfection and transfected with desired pAS plasmids and PiggyBac transposase (PBT) in a 4:1 ratio. Earliest 48 h after transfection, cells were split and selected with different concentrations of appropriate antibiotics for 7 days (ranges: 2–5 μg/mL puromycin (VWR), 500–4000 μg/mL blasticidin (Invivogen), 2000–3000 μg/mL geneticin (G418, Sigma)). Stable integrant cell populations were recovered from the highest submissible selection condition in DMEM +10% FBS (v/v). Polyclonal populations were cultured with ncAA for 24, 48 or 72 h, as indicated, and characterized by flow cytometry for reporter fluorescence and immunoblotting for reporter or protein of interest and PylRS. A list of cell lines generated in this study can be found on Mendeley data (https://doi.org/10.17632/tgc7mbv5xp).

Non-canonical amino acids

Working stocks of ncAAs were prepared in 100 mM NaOH with 15% DMSO (v/v) to 100 mM. Anap working stock was prepared to 20 mM in the same buffer. Chemical structures of N-ε-[(2-methyl-2-cyclopropene-1-yl)-methoxy] carbonyl-L-lysine (CpK), p-azido-phenylalanine (AzF), 3-(6-acetylnaphthalen-2-ylamino)-2-amino-propanoic acid (Anap) and axial trans-cyclooct-2-ene-L-lysine (TCO∗K) are shown in Figures 1, 2, and 5, respectively. Refer to the key resource table for supplier and CAS numbers.

SPIEDAC lysate labeling, SDS-PAGE and immunoblotting

Aliquots of cell lysate were separated on 4–20% Tris-glycine gels (BioRad) and transferred to nitrocellulose membranes (BioRad). Cells were lysed in RIPA (for intracellular proteins) or PBS with 0.1% Triton X-100 (v/v) (cell membrane proteins) supplemented with 1x cOmplete proteinase inhibitor (Roche). The insoluble fraction was removed by centrifugation. To compare amber suppression of PB transgenic integrants generated from different human cells, the soluble fraction of whole cell lysates were normalized for total protein content (BCA assay, Pierce). For SPIEDAC labeling in lysate, 1 μM tetrazine-Silicon rhodamine (tetSiR, Spirochrome) was added to the lysis buffer. Lysates cleared by centrifugation were mixed with 6x Laemmli buffer and denatured for 10 min at 37°C, or at 95°C to completely denature GFP. After separation, gels were exposed at 460 nm, 520 nm and 630 nm in a GE AI600 imager for in-gel fluorescence. Expression of GFP reporter, HA- or GFP-fusion proteins and FLAG-aaRS was confirmed by immunoblotting with antibodies against GFP (Santa Cruz, sc-9996), HA-HRP (Roche, 12013819001), FLAG-HRP (Sigma, A8592), β-actin (cell signaling, 4970), GAPDH (Millipore, AB2302) and corresponding secondary HRP-conjugated antibodies when needed (BioRad). Annotated, preprocessed immunoblotting data can be found on Mendeley data (https://doi.org/10.17632/tgc7mbv5xp).

Quantification of GFP expression

HEK293T-derived cells, selected for pAS_4xMmaPylT/RS and pAS_4xMmaPylT/GFP150TAG PB transposition (low antibiotic concentration: 2 μg/mL puromycin, 500 μg/mL blasticidin), were transiently transfected with an additional pAS plasmid in quadruplicate. Transfected cells were grown in absence or presence (triplicate) of 0.2 mM CpK for 24 h. Cells were lysed in RIPA buffer with 1x cOmplete protease inhibitor (Roche), the insoluble fraction was removed by centrifugation. GFP bottom fluorescence of an aliquot was measured in Tecan Infinite M200 pro plate reader (excitation 485 nm, emission 518 nm). Fluorescence measurements were normalized to total protein content of each sample as determined by Pierce BCA assay kit (Fisher Scientific) on the same sample. Average GFP fluorescence was calculated from the technical triplicates, the GFP fluorescence measured in absence of CpK was subtracted as background fluorescence and values were normalized to average GFP fluorescence measured for the untransfected amber suppression cell line.

Flow cytometry and fluorescence-assisted cell sorting (FACS)

Cells were trypsinized after the indicated time of culturing in presence of ncAAs and resuspended in PBS +10% FBS (v/v). Flow cytometry was carried out on a Beckmann NAVIOS flow cytometer and analyzed in FlowJo software (version 10.6.2) (BD Life Science).

Polyclonal populations selected with antibiotics after PB transgenesis were cultured with the cognate ncAAs for 24 h (GFP150TAG, GFP150TAA, GFP150TGA), 48 h (GFP102TAG150TAA) or 72 h (SynNotch204TAA442TAG-GFP). Single cells were isolated by gating for top 0.4–5% GFP fluorescence signal on a SONY SH800 cell sorter. Clonal populations were expanded in DMEM +10% FBS and analyzed by flow cytometry and immunoblotting for GFP and aaRS expression.

Intact mass spectrometry

The dual suppression GFP102TAG150TAA clonal integrant cell line was cultured in the presence of 0.2 mM and 0.5 mM AzF for 96 h. Cells were lysed in RIPA buffer supplemented with 1x cOmplete protease inhibitor (Roche). The insoluble fraction was removed by centrifugation. Expressed GFP was captured on GFP-Trap_MA magnetic beads (ChromoTEK), washed with RIPA buffer, PBS +500 mM NaCl and PBS prior to elution in 1% (v/v) acetic acid.

Purified GFP102AzF150CpK samples were directly infused into a Waters Synapt G1 traveling-wave IM mass spectrometer (MS Vision, Almere, The Netherlands), with an m/z range of 500–4000 Th. Mass spectra were recorded in positive ionization mode. The capillary voltage was maintained at 1.5 kV and the sample cone was 100 V. The extraction cone voltage was 4 V. The source temperature was maintained +30°C. The trap and transfer collision energies were 10 V. The trap gas was argon at a flow rate of 4 mL/h. Data was analyzed with MassLynx version 4.1 (Waters).

Bioorthogonal labeling on beads

GFP102AzF150CpK and SynNotch204CpK442AzF-GFP were captured on GFP-Trap_MA magnetic beads (ChromoTEK) from cell lysate of the respective PB stable clonal cell lines cultured in presence of 0.5 mM AzF and 0.2 mM CpK for 72 h. Cells were lysed and the insoluble fraction was removed by centrifugation. Beads were washed with RIPA buffer, PBS +500 mM NaCl and PBS. SPIEDAC and SPAAC were carried out on bead-bound proteins simultaneously by adding 1 μM tetSiR (spirochrome) or 1 μM tetCy3 (Click Chemistry Tools) and 1 μM DBCO-TAMRA (Jena Bioscience) or 1 μM DBCO-647 (Jena Bioscience) for 10 min on ice. Excess dye was washed off and bead-bound proteins were eluted with 1% (v/v) acetic acid for SDS-PAGE separation. Equal amounts of GFP purified from different samples were separated on 4–20% Tris-glycine gels (BioRad) and exposed for in-gel fluorescence at 520 nm and 630 nm in a GE AI600 imager. The gel was stained with InstantBlue (Expedeon) to visualize GFP102AzF150CpK bands or transferred to a nitrocellulose membrane for immunostaining against GFP to detect SynNotch204CpK442AzF-GFP.

Live-cell surface SPIEDAC and CuAAC labeling for in-gel fluorescence and fluorescence microscopy

Surface SPIEDAC labeling was performed with 1–2 μM tet488 (Jena Bioscience) or 1-2μM tetCy3 (Click Chemistry Tools) in DMEM +10% FBS (v/v) for 30 min at 37°C. Where indicated SPAAC was carried out with 2 μM DBCO-AF647 (DBCO-647, Click Chemistry Tools) in DMEM +10% FBS (v/v) for 30 min at 37°C. For subsequent CuAAC in the dual suppression cell line, cells were washed with PBS and labeling was performed with 50 μM CuSO4, 250 μM THPTA, 2.5 mM sodium ascorbate and 2 μM alk647 (Jena Bioscience) for 10 min at 22°C. Cells were washed and collected in PBS and lysed in PBS with 0.2% Triton X-100 (v/v) and 1x complete protease inhibitor (Roche) on ice. Lysates cleared by centrifugation were mixed with 6x Laemmli buffer and denatured for 10 min at 37°C, or at 95°C to completely denature GFP. Proteins were separated by SDS-PAGE and in-gel fluorescence measured as described above. Alternatively, for cells grown on poly-L-lysine coated 18-well glass imaging slides (Ibidi), cells were washed with PBS, fixed in paraformaldehyde (PFA) 4% (v/v) and counterstained with 2 μM hoechst 33342 prior to imaging in PBS on a Nikon Eclipse Ti2 inverted widefield microscope, using a 20x (0.75 NA) objective and filter sets for DAPI, GFP, Cy3 and Cy5 fluorescence. Images were processed in Fiji.50 To ensure comparability of fluorescence signal between images from different samples, images were acquired at constant settings for each filter set after initial adjustment. Images collected with each filter set were processed as stacks in Fiji.

Intracellular SPIEDAC labeling and immunofluorescence microscopy

HCT116 PB integrant polyclonal population expressing tRNAPyl, PylRS AF and gene of interest (GOI) were seeded at 15 000 cells per well on poly-L-lysine coated 96 well imaging plates (Ibidi) in presence of 0.1 mM TCO∗K for 48 h. Subsequently, the cells were washed with PBS, fixed in 4% PFA) for 10 min, permeabilized in PBS with 0.1% Triton X-100 (v/v) (PBS-T), blocked in 2% BSA in PBS-T and stained with 0.5 μM methyltetrazine-BDP-FL (metetBDPFL) (Jena Bioscience) for 1 h at RT, incubated with primary anti-HA antibody (Santa Cruz, sc-7392) followed by incubation with secondary 555-coupled antibody (Life Technologies, A-31570) and 2 μM Hoechst 33342 (Life Technologies). The cells were washed and imaged in PBS on a Nikon Eclipse Ti2 inverted widefield microscope, using a 20x (0.75 NA) objective and filters sets for DAPI, AF488, Cy3 and Cy5 fluorescence.

Quantification and statistical analysis

An unpaired, homoscedastic, two-tailed t-test was used to compare GFP fluorescence signal. The significance was defined incrementally using thresholds of p < 0.05 and p < 0.01 as indicated. Samples sizes are described in the figures and figure legends.

Acknowledgments

We thank all members of the Elsässer lab for input and the other groups in the Division of Genome Biology for their support; the J. Bartek lab for access to a Tecan Infinite M200 Pro Plate Reader and a Nikon Eclipse Ti2 Microscope; and the O. Fernandez-Capetillo lab for access to a GE AI600 gel imager. Research was funded by Vetenskapsrådet, Sweden (2015–04815); the Ming Wai Lau Center for Reparative Medicine, Sweden; the Ragnar Söderbergs stiftelse, Sweden; Stiftelsen för Strategisk Forskning (FFL7); and the Knut och Alice Wallenbergs Stiftelse, Sweden (2017–0276).

Author contributions

B.M. and S.J.E. conceived and designed experiments. B.M., J.H., and M.F.P. generated plasmids. B.M., J.H., and R.C. generated stable cell lines. J.H. and B.M. performed fluorescence microscopy. B.M., R.C., K.J.K., and M.F.B. isolated clonal cell populations. M.L. performed intact mass spectrometry measurements and analyzed data. B.M. and S.J.E. analyzed data. BM prepared figures. B.M., J.H., and S.J.E. wrote the manuscript. All authors read the manuscript.

Declaration of interests

The authors declare no competing interests.

Published: November 6, 2023

Footnotes

Supplemental information can be found online at https://doi.org/10.1016/j.crmeth.2023.100626.

Contributor Information

Birthe Meineke, Email: birthe.meineke@scilifelab.se.

Simon J. Elsässer, Email: simon.elsasser@scilifelab.se.

Supplemental information

Document S1. Figures S1–S6
mmc1.pdf (15.4MB, pdf)
Document S2. Article plus supplemental information
mmc2.pdf (20.1MB, pdf)

References

  • 1.de la Torre D., Chin J.W. Reprogramming the genetic code. Nat. Rev. Genet. 2021;22:169–184. doi: 10.1038/s41576-020-00307-7. [DOI] [PubMed] [Google Scholar]
  • 2.Shandell M.A., Tan Z., Cornish V.W. Genetic code expansion: A brief history and perspective. Biochemistry. 2021;60:3455–3469. doi: 10.1021/acs.biochem.1c00286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Xiao H., Chatterjee A., Choi S.h., Bajjuri K.M., Sinha S.C., Schultz P.G. Genetic incorporation of multiple unnatural amino acids into proteins in mammalian cells. Angew. Chem. Int. Ed. 2013;52:14080–14083. doi: 10.1002/anie.201308137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zheng Y., Addy P.S., Mukherjee R., Chatterjee A. Defining the current scope and limitations of dual noncanonical amino acid mutagenesis in mammalian cells. Chem. Sci. 2017;8:7211–7217. doi: 10.1039/c7sc02560b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Meineke B., Heimgärtner J., Lafranchi L., Elsässer S.J. Methanomethylophilus alvus Mx1201 Provides Basis for Mutual Orthogonal Pyrrolysyl tRNA/Aminoacyl-tRNA Synthetase Pairs in Mammalian Cells. ACS Chem. Biol. 2018;13:3087–3096. doi: 10.1021/acschembio.8b00571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Serfling R., Lorenz C., Etzel M., Schicht G., Böttke T., Mörl M., Coin I. Designer tRNAs for efficient incorporation of non-canonical amino acids by the pyrrolysine system in mammalian cells. Nucleic Acids Res. 2018;46:1–10. doi: 10.1093/nar/gkx1156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Beránek V., Willis J.C.W., Chin J.W. An Evolved Methanomethylophilus alvus Pyrrolysyl-tRNA Synthetase/tRNA Pair Is Highly Active and Orthogonal in Mammalian Cells. Biochemistry. 2019;58:387–390. doi: 10.1021/acs.biochem.8b00808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Meineke B., Heimgärtner J., Eirich J., Landreh M., Elsässer S.J. Site-Specific Incorporation of Two ncAAs for Two-Color Bioorthogonal Labeling and Crosslinking of Proteins on Live Mammalian Cells. Cell Rep. 2020;31 doi: 10.1016/j.celrep.2020.107811. [DOI] [PubMed] [Google Scholar]
  • 9.Osgood A.O., Zheng Y., Roy S.J.S., Biris N., Hussain M., Loynd C., Jewel D., Italia J.S., Chatterjee A. An Efficient Opal-Suppressor Tryptophanyl Pair Creates New Routes for Simultaneously Incorporating up to Three Distinct Noncanonical Amino Acids into Proteins in Mammalian Cells. Angew. Chem. Int. Ed. 2023;62 doi: 10.1002/anie.202219269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rother M., Krzycki J.A. Selenocysteine, pyrrolysine, and the unique energy metabolism of methanogenic archaea. Archaea. 2010;2010:453642. doi: 10.1155/2010/453642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Srinivasan G., James C.M., Krzycki J.A. Pyrrolysine encoded by UAG in Archaea: charging of a UAG-decoding specialized tRNA. Science. 2002;296:1459–1462. doi: 10.1126/science.1069588. [DOI] [PubMed] [Google Scholar]
  • 12.Ambrogelly A., Gundllapalli S., Herring S., Polycarpo C., Frauer C., Söll D. Pyrrolysine is not hardwired for cotranslational insertion at UAG codons. Proc. Natl. Acad. Sci. USA. 2007;104:3141–3146. doi: 10.1073/pnas.0611634104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wan W., Tharp J.M., Liu W.R. Pyrrolysyl-tRNA synthetase: an ordinary enzyme but an outstanding genetic code expansion tool. Biochim. Biophys. Acta. 2014;1844:1059–1070. doi: 10.1016/j.bbapap.2014.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Suzuki T., Miller C., Guo L.-T., Ho J.M.L., Bryson D.I., Wang Y.-S., Liu D.R., Söll D. Crystal structures reveal an elusive functional domain of pyrrolysyl-tRNA synthetase. Nat. Chem. Biol. 2017;13:1261–1266. doi: 10.1038/nchembio.2497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Chin J.W. Expanding and reprogramming the genetic code of cells and animals. Annu. Rev. Biochem. 2014;83:379–408. doi: 10.1146/annurev-biochem-060713-035737. [DOI] [PubMed] [Google Scholar]
  • 16.Italia J.S., Latour C., Wrobel C.J.J., Chatterjee A. Resurrecting the Bacterial Tyrosyl-tRNA Synthetase/tRNA Pair for Expanding the Genetic Code of Both E. coli and Eukaryotes. Cell Chem. Biol. 2018;25:1304–1312.e5. doi: 10.1016/j.chembiol.2018.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sakamoto K., Hayashi A., Sakamoto A., Kiga D., Nakayama H., Soma A., Kobayashi T., Kitabatake M., Takio K., Saito K., et al. Site-specific incorporation of an unnatural amino acid into proteins in mammalian cells. Nucleic Acids Res. 2002;30:4692–4699. doi: 10.1093/nar/gkf589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chin J.W., Cropp T.A., Anderson J.C., Mukherji M., Zhang Z., Schultz P.G. An expanded eukaryotic genetic code. Science. 2003;301:964–967. doi: 10.1126/science.1084772. [DOI] [PubMed] [Google Scholar]
  • 19.Liu W., Brock A., Chen S., Chen S., Schultz P.G. Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nat. Methods. 2007;4:239–244. doi: 10.1038/nmeth1016. [DOI] [PubMed] [Google Scholar]
  • 20.Grasso K.T., Singha Roy S.J., Osgood A.O., Yeo M.J.R., Soni C., Hillenbrand C.M., Ficaretta E.D., Chatterjee A. A Facile Platform to Engineer Escherichia coli Tyrosyl-tRNA Synthetase Adds New Chemistries to the Eukaryotic Genetic Code, Including a Phosphotyrosine Mimic. ACS Cent. Sci. 2022;8:483–492. doi: 10.1021/acscentsci.1c01465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lee H.S., Guo J., Lemke E.A., Dimla R.D., Schultz P.G. Genetic incorporation of a small, environmentally sensitive, fluorescent probe into proteins in Saccharomyces cerevisiae. J. Am. Chem. Soc. 2009;131:12921–12923. doi: 10.1021/ja904896s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chatterjee A., Guo J., Lee H.S., Schultz P.G. A genetically encoded fluorescent probe in mammalian cells. J. Am. Chem. Soc. 2013;135:12540–12543. doi: 10.1021/ja4059553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wu N., Deiters A., Cropp T.A., King D., Schultz P.G. A genetically encoded photocaged amino acid. J. Am. Chem. Soc. 2004;126:14306–14307. doi: 10.1021/ja040175z. [DOI] [PubMed] [Google Scholar]
  • 24.Muerdter F., Boryń Ł.M., Woodfin A.R., Neumayr C., Rath M., Zabidi M.A., Pagani M., Haberle V., Kazmar T., Catarino R.R., et al. Resolving systematic errors in widely used enhancer activity assays in human cells. Nat. Methods. 2018;15:141–149. doi: 10.1038/nmeth.4534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Elsässer S.J., Ernst R.J., Walker O.S., Chin J.W. Genetic code expansion in stable cell lines enables encoded chromatin modification. Nat. Methods. 2016;13:158–164. doi: 10.1038/nmeth.3701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Elsässer S.J. Generation of stable amber suppression cell lines. Methods Mol. Biol. 2018;1728:237–245. doi: 10.1007/978-1-4939-7574-7_15. [DOI] [PubMed] [Google Scholar]
  • 27.van Husen L.S., Katsori A.M., Meineke B., Tjernberg L.O., Schedin-Weiss S., Elsässer S.J. Engineered human induced pluripotent cells enable genetic code expansion in brain organoids. Chembiochem. 2021;22:3208–3213. doi: 10.1002/cbic.202100399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ding S., Wu X., Li G., Han M., Zhuang Y., Xu T. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell. 2005;122:473–483. doi: 10.1016/j.cell.2005.07.013. [DOI] [PubMed] [Google Scholar]
  • 29.Bartoschek M.D., Ugur E., Nguyen T.-A., Rodschinka G., Wierer M., Lang K., Bultmann S. Identification of permissive amber suppression sites for efficient non-canonical amino acid incorporation in mammalian cells. Nucleic Acids Res. 2021;49:e62. doi: 10.1093/nar/gkab132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zhou W., Wesalo J.S., Liu J., Deiters A. Genetic code expansion in mammalian cells: A plasmid system comparison. Bioorg. Med. Chem. 2020;28 doi: 10.1016/j.bmc.2020.115772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lafranchi L., Schlesinger D., Kimler K.J., Elsässer S.J. Universal Single-Residue Terminal Labels for Fluorescent Live Cell Imaging of Microproteins. J. Am. Chem. Soc. 2020;142:20080–20087. doi: 10.1021/jacs.0c09574. [DOI] [PubMed] [Google Scholar]
  • 32.Elliott T.S., Townsley F.M., Bianco A., Ernst R.J., Sachdeva A., Elsässer S.J., Davis L., Lang K., Pisa R., Greiss S., et al. Proteome labeling and protein identification in specific tissues and at specific developmental stages in an animal. Nat. Biotechnol. 2014;32:465–472. doi: 10.1038/nbt.2860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Schmied W.H., Elsässer S.J., Uttamapinant C., Chin J.W. Efficient multisite unnatural amino acid incorporation in mammalian cells via optimized pyrrolysyl tRNA synthetase/tRNA expression and engineered eRF1. J. Am. Chem. Soc. 2014;136:15577–15583. doi: 10.1021/ja5069728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zheng Y., Lewis T.L., Igo P., Polleux F., Chatterjee A. Virus-Enabled Optimization and Delivery of the Genetic Machinery for Efficient Unnatural Amino Acid Mutagenesis in Mammalian Cells and Tissues. ACS Synth. Biol. 2017;6:13–18. doi: 10.1021/acssynbio.6b00092. [DOI] [PubMed] [Google Scholar]
  • 35.Jewel D., Kelemen R.E., Huang R.L., Zhu Z., Sundaresh B., Cao X., Malley K., Huang Z., Pasha M., Anthony J., et al. Virus-assisted directed evolution of enhanced suppressor tRNAs in mammalian cells. Nat. Methods. 2023;20:95–103. doi: 10.1038/s41592-022-01706-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bryson D.I., Fan C., Guo L.-T., Miller C., Söll D., Liu D.R. Continuous directed evolution of aminoacyl-tRNA synthetases. Nat. Chem. Biol. 2017;13:1253–1260. doi: 10.1038/nchembio.2474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ai H.w., Shen W., Sagi A., Chen P.R., Schultz P.G. Probing protein-protein interactions with a genetically encoded photo-crosslinking amino acid. Chembiochem. 2011;12:1854–1857. doi: 10.1002/cbic.201100194. [DOI] [PubMed] [Google Scholar]
  • 38.Gautier A., Nguyen D.P., Lusic H., An W., Deiters A., Chin J.W. Genetically encoded photocontrol of protein localization in mammalian cells. J. Am. Chem. Soc. 2010;132:4086–4088. doi: 10.1021/ja910688s. [DOI] [PubMed] [Google Scholar]
  • 39.Floquet C., Hatin I., Rousset J.-P., Bidou L. Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin. PLoS Genet. 2012;8 doi: 10.1371/journal.pgen.1002608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Palomar-Siles M., Heldin A., Zhang M., Strandgren C., Yurevych V., van Dinter J.T., Engels S.A.G., Hofman D.A., Öhlin S., Meineke B., et al. Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine. Cell Death Dis. 2022;13:997. doi: 10.1038/s41419-022-05431-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Nikić I., Plass T., Schraidt O., Szymański J., Briggs J.A.G., Schultz C., Lemke E.A. Minimal tags for rapid dual-color live-cell labeling and super-resolution microscopy. Angew. Chem. Int. Ed. 2014;53:2245–2249. doi: 10.1002/anie.201309847. [DOI] [PubMed] [Google Scholar]
  • 42.Yanagisawa T., Ishii R., Fukunaga R., Kobayashi T., Sakamoto K., Yokoyama S. Multistep engineering of pyrrolysyl-tRNA synthetase to genetically encode N(epsilon)-(o-azidobenzyloxycarbonyl) lysine for site-specific protein modification. Chem. Biol. 2008;15:1187–1197. doi: 10.1016/j.chembiol.2008.10.004. [DOI] [PubMed] [Google Scholar]
  • 43.Fliedl L., Kast F., Grillari J., Wieser M., Grillari-Voglauer R. Optimization of a quantitative PCR based method for plasmid copy number determination in human cell lines. N. Biotechnol. 2015;32:716–719. doi: 10.1016/j.nbt.2015.03.004. [DOI] [PubMed] [Google Scholar]
  • 44.Coin I., Katritch V., Sun T., Xiang Z., Siu F.Y., Beyermann M., Stevens R.C., Wang L. Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCR. Cell. 2013;155:1258–1269. doi: 10.1016/j.cell.2013.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Meineke B., Heimgärtner J., Craig A.J., Landreh M., Moodie L.W.K., Elsässer S.J. A genetically encoded picolyl azide for improved live cell copper click labeling. Front. Chem. 2021;9 doi: 10.3389/fchem.2021.768535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Morsut L., Roybal K.T., Xiong X., Gordley R.M., Coyle S.M., Thomson M., Lim W.A. Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell. 2016;164:780–791. doi: 10.1016/j.cell.2016.01.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.van Geel R., Pruijn G.J.M., van Delft F.L., Boelens W.C. Preventing thiol-yne addition improves the specificity of strain-promoted azide-alkyne cycloaddition. Bioconjug. Chem. 2012;23:392–398. doi: 10.1021/bc200365k. [DOI] [PubMed] [Google Scholar]
  • 48.Shao S., Koh M., Schultz P.G. Expanding the genetic code of the human hematopoietic system. Proc. Natl. Acad. Sci. USA. 2020;117:8845–8849. doi: 10.1073/pnas.1914408117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Oller-Salvia B., Kym G., Chin J.W. Rapid and Efficient Generation of Stable Antibody-Drug Conjugates via an Encoded Cyclopropene and an Inverse-Electron-Demand Diels-Alder Reaction. Angew. Chem. Int. Ed. 2018;57:2831–2834. doi: 10.1002/anie.201712370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Axup J.Y., Bajjuri K.M., Ritland M., Hutchins B.M., Kim C.H., Kazane S.A., Halder R., Forsyth J.S., Santidrian A.F., Stafin K., et al. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc. Natl. Acad. Sci. USA. 2012;109:16101–16106. doi: 10.1073/pnas.1211023109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Figures S1–S6
mmc1.pdf (15.4MB, pdf)
Document S2. Article plus supplemental information
mmc2.pdf (20.1MB, pdf)

Data Availability Statement

  • Raw images have been deposited to Mendeley data, see key resources table for the DOI. All other primary data will be shared by the lead contact upon request.

  • This paper does not report original code.

  • Any other information required to reanalyze the data in this paper will be shared by the lead contact upon request.


Articles from Cell Reports Methods are provided here courtesy of Elsevier

RESOURCES